carbapenem

(redirected from Carbapenem antibiotics)
Also found in: Dictionary.

carbapenem

(kahr-bă-pen'em),
Member of a class of antibiotic drugs that works by inhibiting cell wall synthesis.

carbapenem

(kär′bə-pĕn′əm)
n.
Any of several semisynthetic or synthetic beta-lactam antibiotics that are used chiefly to treat serious infections caused by bacteria that are resistant to other antibiotics.

carbapenem

A class of antibiotics with a broad spectrum of action against gram-positive, gram-negative, and anaerobic germs. The carbapenems include imipenem and meropenem.
References in periodicals archive ?
pneumoniae were the main pathogens;[sup][5],[6] drug sensitivity tests showed that there were varying degrees of resistance to carbapenem antibiotics.
Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid.
Carbapenem antibiotics are widely used in hospitals to treat severe infections.
The carbapenem antibiotic disks used for each isolate were ertapenem (10mg), imipenem (10mg), meropenem (10mg) and doripenem (10mg).
According to the report, resistance to the treatment of last resort for life- threatening infections caused by a common intestinal bacteria, Klebsiella pneumonia -- carbapenem antibiotics -- has spread to the entire world.
Key findings from the report included that resistance to the treatment of last resort for life-threatening infections caused by a common intestinal bacteria, Klebsiella pneumoniae carbapenem antibiotics has spread to all regions of the world.
Prof Neil Woodford, of Public Health England, said: "KPC is one of a number of enzymes that can make a bacteria resistant to carbapenem antibiotics.
In some parts of the world, only the carbapenem antibiotics class remains effective, but now signs are emerging of resistance even to this last line of defence.
Carbapenem antibiotics should be treated as the last resort and reserved for severe infections.
In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
Key Topics Covered: - China Antibiotics Market In Globalization Process, 2009 - China Antibiotics Foreign Trade, 2007-2008 - China Antibiotics Market, 2008 - China Antibiotics Market after 2010 - China Anti-Infective Drug Market - China Antibiotics Retail Market - Children Oral Antibiotics Market - Cephalosporins Antibiotics Market - Penicillin Antibiotics Market - Carbapenem Antibiotics Market - Macrolide Antibiotics Market - Quinolones Antibiotics Market - Beta-lactams Antibiotics Market - Polypeptide Antibiotics Market - Market Competition - List of Charts Companies Mentioned: - Yangtze River Pharmaceutical Group - Shanghai Roche Pharmaceuticals Co.
Resistance to carbapenem antibiotics was detected at very low level in poultry and in chicken meat in two Member States (fifteen E.